TY  - CONF 
AU  - Bello López, José Luis
PY  - 2013
SN  - 0278-0232
UR  - http://hdl.handle.net/20.500.11940/4189
LA  - eng
TI  - BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)
DO  - 10.1002/hon.2057
VL  - 31
ER  -